Article
Late infantile metachromatic leukodystrophy in Israel.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Jan 1994
Zlotogora J, Gieselman V, von Figura K, Zeigler M, Bach G
Abstract excerpt
Metachromatic Leukodystrophy (MLD) is a neurodegenerative disease in which the lysosomal enzyme, Aryl sulfatase A (ARSA) is deficient. The disease is inherited as an autosomal recessive trait and its frequency is estimated to be 1/40,000 live births. The gene of ARSA has been cloned and up to now eight mutations causing MLD have been reported. Another mutation, PD, leads to the deficiency of the enzyme in vitro...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
